tafamidis meglumine 20 MG Oral Capsule [Vyndaqel]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

tafamidis meglumine 20 MG Oral Capsule [Vyndaqel]

20 MG · Oral Capsule · oral

A form of tafamidis meglumine →

tafamidis meglumine 20 MG Oral Capsule [Vyndaqel] — Other nervous system drugs. Strength, form, class, interactions & more.

tafamidis meglumine 20 MG Oral Capsule [Vyndaqel]

Active ingredient

Classification

Other nervous system drugs

Drug interactions

Tafamidis may increase the exposure and toxicity of certain BCRP substrates when coadministered.

  • majorBCRP substrates (e.g., methotrexate, rosuvastatin, imatinib) — increased exposure and risk of substrate-related toxicities

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.